vs

Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and POTLATCHDELTIC CORP (PCH). Click either name above to swap in a different company.

POTLATCHDELTIC CORP is the larger business by last-quarter revenue ($314.2M vs $205.4M, roughly 1.5× COLLEGIUM PHARMACEUTICAL, INC). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs 8.2%, a 0.0% gap on every dollar of revenue. On growth, POTLATCHDELTIC CORP posted the faster year-over-year revenue change (23.1% vs 12.9%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $50.1M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 11.1%).

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.

PotlatchDeltic Corporation is an American diversified forest products company based in Spokane, Washington.

COLL vs PCH — Head-to-Head

Bigger by revenue
PCH
PCH
1.5× larger
PCH
$314.2M
$205.4M
COLL
Growing faster (revenue YoY)
PCH
PCH
+10.2% gap
PCH
23.1%
12.9%
COLL
Higher net margin
COLL
COLL
0.0% more per $
COLL
8.3%
8.2%
PCH
More free cash flow
COLL
COLL
$72.2M more FCF
COLL
$122.4M
$50.1M
PCH
Faster 2-yr revenue CAGR
COLL
COLL
Annualised
COLL
19.1%
11.1%
PCH

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
COLL
COLL
PCH
PCH
Revenue
$205.4M
$314.2M
Net Profit
$17.0M
$25.9M
Gross Margin
62.5%
18.2%
Operating Margin
29.6%
11.2%
Net Margin
8.3%
8.2%
Revenue YoY
12.9%
23.1%
Net Profit YoY
35.3%
682.5%
EPS (diluted)
$0.48
$0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COLL
COLL
PCH
PCH
Q4 25
$205.4M
Q3 25
$209.4M
$314.2M
Q2 25
$188.0M
$275.0M
Q1 25
$177.8M
$268.3M
Q4 24
$181.9M
$258.1M
Q3 24
$159.3M
$255.1M
Q2 24
$145.3M
$320.7M
Q1 24
$144.9M
$228.1M
Net Profit
COLL
COLL
PCH
PCH
Q4 25
$17.0M
Q3 25
$31.5M
$25.9M
Q2 25
$12.0M
$7.4M
Q1 25
$2.4M
$25.8M
Q4 24
$12.5M
$5.2M
Q3 24
$9.3M
$3.3M
Q2 24
$19.6M
$13.7M
Q1 24
$27.7M
$-305.0K
Gross Margin
COLL
COLL
PCH
PCH
Q4 25
62.5%
Q3 25
61.7%
18.2%
Q2 25
57.7%
13.0%
Q1 25
54.8%
17.8%
Q4 24
54.0%
13.4%
Q3 24
60.8%
10.8%
Q2 24
62.5%
11.9%
Q1 24
63.1%
7.0%
Operating Margin
COLL
COLL
PCH
PCH
Q4 25
29.6%
Q3 25
29.7%
11.2%
Q2 25
18.7%
5.0%
Q1 25
12.2%
10.3%
Q4 24
20.9%
5.2%
Q3 24
21.9%
2.8%
Q2 24
32.7%
5.4%
Q1 24
34.1%
-2.1%
Net Margin
COLL
COLL
PCH
PCH
Q4 25
8.3%
Q3 25
15.0%
8.2%
Q2 25
6.4%
2.7%
Q1 25
1.4%
9.6%
Q4 24
6.9%
2.0%
Q3 24
5.9%
1.3%
Q2 24
13.5%
4.3%
Q1 24
19.1%
-0.1%
EPS (diluted)
COLL
COLL
PCH
PCH
Q4 25
$0.48
Q3 25
$0.84
$0.33
Q2 25
$0.34
$0.09
Q1 25
$0.07
$0.33
Q4 24
$0.36
$0.07
Q3 24
$0.27
$0.04
Q2 24
$0.52
$0.17
Q1 24
$0.71
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COLL
COLL
PCH
PCH
Cash + ST InvestmentsLiquidity on hand
$386.7M
$88.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$301.7M
$1.9B
Total Assets
$1.7B
$3.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COLL
COLL
PCH
PCH
Q4 25
$386.7M
Q3 25
$285.9M
$88.8M
Q2 25
$222.2M
$95.3M
Q1 25
$197.8M
$147.5M
Q4 24
$162.8M
$151.6M
Q3 24
$120.0M
$161.1M
Q2 24
$271.6M
$199.7M
Q1 24
$318.0M
$180.2M
Total Debt
COLL
COLL
PCH
PCH
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.0B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
COLL
COLL
PCH
PCH
Q4 25
$301.7M
Q3 25
$274.8M
$1.9B
Q2 25
$232.2M
$1.9B
Q1 25
$234.4M
$2.0B
Q4 24
$228.8M
$2.0B
Q3 24
$234.3M
$2.1B
Q2 24
$216.6M
$2.1B
Q1 24
$222.2M
$2.2B
Total Assets
COLL
COLL
PCH
PCH
Q4 25
$1.7B
Q3 25
$1.6B
$3.2B
Q2 25
$1.6B
$3.2B
Q1 25
$1.6B
$3.3B
Q4 24
$1.7B
$3.3B
Q3 24
$1.6B
$3.3B
Q2 24
$1.1B
$3.4B
Q1 24
$1.1B
$3.4B
Debt / Equity
COLL
COLL
PCH
PCH
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.51×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COLL
COLL
PCH
PCH
Operating Cash FlowLast quarter
$123.0M
$65.7M
Free Cash FlowOCF − Capex
$122.4M
$50.1M
FCF MarginFCF / Revenue
59.6%
15.9%
Capex IntensityCapex / Revenue
0.3%
4.9%
Cash ConversionOCF / Net Profit
7.25×
2.54×
TTM Free Cash FlowTrailing 4 quarters
$327.6M
$132.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COLL
COLL
PCH
PCH
Q4 25
$123.0M
Q3 25
$78.4M
$65.7M
Q2 25
$72.4M
$41.0M
Q1 25
$55.4M
$49.1M
Q4 24
$84.6M
$45.4M
Q3 24
$-9.0M
$26.5M
Q2 24
$67.4M
$100.6M
Q1 24
$61.9M
$16.0M
Free Cash Flow
COLL
COLL
PCH
PCH
Q4 25
$122.4M
Q3 25
$78.3M
$50.1M
Q2 25
$72.4M
$30.6M
Q1 25
$54.6M
$26.3M
Q4 24
$84.1M
$25.4M
Q3 24
$-9.2M
$-8.2M
Q2 24
$67.1M
$72.4M
Q1 24
$61.4M
$2.0M
FCF Margin
COLL
COLL
PCH
PCH
Q4 25
59.6%
Q3 25
37.4%
15.9%
Q2 25
38.5%
11.1%
Q1 25
30.7%
9.8%
Q4 24
46.2%
9.9%
Q3 24
-5.8%
-3.2%
Q2 24
46.2%
22.6%
Q1 24
42.3%
0.9%
Capex Intensity
COLL
COLL
PCH
PCH
Q4 25
0.3%
Q3 25
0.1%
4.9%
Q2 25
0.0%
3.8%
Q1 25
0.4%
8.5%
Q4 24
0.3%
7.7%
Q3 24
0.2%
13.6%
Q2 24
0.2%
8.8%
Q1 24
0.4%
6.1%
Cash Conversion
COLL
COLL
PCH
PCH
Q4 25
7.25×
Q3 25
2.49×
2.54×
Q2 25
6.05×
5.58×
Q1 25
22.92×
1.90×
Q4 24
6.75×
8.74×
Q3 24
-0.96×
7.99×
Q2 24
3.44×
7.35×
Q1 24
2.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

COLL
COLL

Segment breakdown not available.

PCH
PCH

Lumber$131.8M42%
Timberlands$52.5M17%
Rural Real Estate$51.3M16%
Residuals And Panels$34.0M11%
Pulpwood$16.7M5%
Development Real Estate$14.6M5%
Other$8.1M3%
Other Products$5.2M2%

Related Comparisons